Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Colorectal Neoplasms

Free Subscription 08.04.2019 1 Ann Surg 2 Ann Surg Oncol 4 BMC Cancer 4 Br J Cancer 1 Br J Surg 1 Cancer Res 1 Clin Cancer Res 1 Curr Treat Options Oncol 1 Eur J Surg Oncol 3 Gastroenterology 3 Gastrointest Endosc 2 Int J Cancer 1 Int J Oncol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg

1. STOMMEL MWJ, Ten Broek RPG, Strik C, Slooter GD, et al
   Multicenter Observational Study of Adhesion Formation After Open-and Laparoscopic Surgery for Colorectal Cancer.
   Ann Surg. 2018;267:743-748.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

2. BROMAN KK, Bailey CE, Parikh AA
   Sidedness of Colorectal Cancer Impacts Risk of Second Primary Gastrointestinal Malignancy.
   Ann Surg Oncol. 2019 Apr 4. pii: 10.1245/s10434-019-07326.
   PubMed     Text format     Abstract available
   
   
3. SHULMAN LN, Browner AE, Palis BE, Mallin K, et al
   Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Rese
   Ann Surg Oncol. 2019 Mar 29. pii: 10.1245/s10434-019-07323.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

4. WU YY, Zhang X, Qin YY, Qin JQ, et al
   Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study.
   BMC Cancer. 2019;19:314.
   PubMed     Text format     Abstract available
   
   
5. GARCIA-TORRECILLAS JM, Olvera-Porcel MC, Ferrer-Marquez M, Rubio-Gil F, et al
   Spatial and temporal variations in Spain in the standardised ratio of in-hospital mortality due to colorectal cancer, 2008-2014.
   BMC Cancer. 2019;19:310.
   PubMed     Text format     Abstract available
   
   
6. ROTHE F, Maetens M, Rouas G, Paesmans M, et al
   CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
   BMC Cancer. 2019;19:304.
   PubMed     Text format     Abstract available
   
   
7. SHARAF LK, Sharma M, Chandel D, Shukla G, et al
   Prophylactic intervention of probiotics (L.acidophilus, L.rhamnosus GG) and celecoxib modulate Bax-mediated apoptosis in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis.
   BMC Cancer. 2018;18:1111.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

8. YUZHALIN AE, Urbonas T, Silva MA, Muschel RJ, et al
   A core matrisome gene signature predicts cancer outcome.
   Br J Cancer. 2018;118:435-440.
   PubMed     Text format     Abstract available
   
   
9. NIEMINEN MT, Listyarifah D, Hagstrom J, Haglund C, et al
   Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation.
   Br J Cancer. 2018;118:428-434.
   PubMed     Text format     Abstract available
   
   
10. MOON JH, Hong SW, Kim JE, Shin JS, et al
    Targeting beta-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
    Br J Cancer. 2019 Apr 4. pii: 10.1038/s41416-019-0434.
    PubMed     Text format     Abstract available
    
    
11. KATHER JN, Halama N
    Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer.
    Br J Cancer. 2019 Apr 2. pii: 10.1038/s41416-019-0441.
    PubMed     Text format     Abstract available
    
    

    
    Br J Surg

12. REYNOLDS IS, Furney SJ, Kay EW, McNamara DA, et al
    Meta-analysis of the molecular associations of mucinous colorectal cancer.
    Br J Surg. 2019 Apr 4. doi: 10.1002/bjs.11142.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

13. WALKER-SAMUEL S, Roberts TA, Ramasawmy R, Burrell JS, et al
    Investigating Low-Velocity Fluid Flow in Tumors with Convection-MRI.
    Cancer Res. 2018;78:1859-1872.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

14. MARSHALL JF
    Targeting CDH17 in Cancer: When Blocking the Ligand Beats Blocking the Receptor?
    Clin Cancer Res. 2018;24:253-255.
    PubMed     Text format     Abstract available
    
    

    
    Curr Treat Options Oncol

15. SIMARD J, Kamath S, Kircher S
    Survivorship Guidance for Patients with Colorectal Cancer.
    Curr Treat Options Oncol. 2019;20:38.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

16. DAZA JF, Solis NM, Parpia S, Gallinger S, et al
    A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
    Eur J Surg Oncol. 2019 Mar 21. pii: S0748-7983(19)30353.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

17. LADABAUM U, Mannalithara A, Meester RGS, Gupta S, et al
    Cost-effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-risk Persons at Age 45 Years Instead of 50 Years.
    Gastroenterology. 2019 Mar 28. pii: S0016-5085(19)33578.
    PubMed     Text format     Abstract available
    
    
18. SPAANDER MCW, Kuipers EJ
    Oral Anticoagulants and Aspirin Use and Its Effect on Positive Predictive Value of Fecal Immunochemical Test for Advanced Neoplasia in Colorectal Cancer Screening: To Bleed or Not to Bleed.
    Gastroenterology. 2019 Mar 26. pii: S0016-5085(19)34587.
    PubMed     Text format    
    
    
19. HAYAKAWA Y, Tsuboi M, Asfaha S, Kinoshita H, et al
    BHLHA15-Positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.
    Gastroenterology. 2019;156:1066-1081.
    PubMed     Text format     Abstract available
    
    

    
    Gastrointest Endosc

20. LIN OS
    Response.
    Gastrointest Endosc. 2019;89:901-902.
    PubMed     Text format    
    
    
21. SANTOS AL, Peixoto A, Silva M, Costa-Moreira P, et al
    Malignant and premalignant colorectal lesions in the 40s: The new generation to be screened?
    Gastrointest Endosc. 2019;89:901.
    PubMed     Text format    
    
    
22. ERTEM FU, Ladabaum U, Schoen RE
    Response.
    Gastrointest Endosc. 2019;89:896-897.
    PubMed     Text format    
    
    

    
    Int J Cancer

23. HOFFMEISTER M, Holleczek B, Stock C, Zwink N, et al
    Utilization and determinants of follow-up colonoscopies within 6 years after screening colonoscopy: Prospective cohort study.
    Int J Cancer. 2019;144:402-410.
    PubMed     Text format     Abstract available
    
    
24. SOW HS, Benonisson H, Breukel C, Visser R, et al
    FcgammaR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model.
    Int J Cancer. 2019;144:345-354.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

25. CAI Z, Wang L, Han Y, Gao W, et al
    Immunoglobulinlike transcript 4 and human leukocyte antigenG interaction promotes the progression of human colorectal cancer.
    Int J Oncol. 2019 Mar 22. doi: 10.3892/ijo.2019.4761.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

26. FENG YY, Zeng DZ, Tong YN, Lu XX, et al
    Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
    PLoS One. 2019;14:e0215088.
    PubMed     Text format     Abstract available
    
    
27. PEACOCK SD, Massey TE, Vanner SJ, King WD, et al
    Telomere length in the colon is related to colorectal adenoma prevalence.
    PLoS One. 2018;13:e0205697.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: